CKD-378
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
May 21, 2025
Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=31 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
November 29, 2024
Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
July 08, 2024
A Clinical Trial to Evaluate the Food Effect of CKD-378
(clinicaltrials.gov)
- P1 | N=31 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Active, not recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
May 29, 2024
A Clinical Trial to Evaluate the Food Effect of CKD-378
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
April 26, 2024
A Clinical Trial to Evaluate the Food Effect of CKD-378
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
March 12, 2024
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed | Trial completion date: May 2023 ➔ Sep 2023 | Trial primary completion date: May 2023 ➔ Aug 2023
Trial completion • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
December 19, 2023
Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=23 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
May 31, 2023
Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 8
Of
8
Go to page
1